Gilteritinib is a targeted therapy used in the treatment of acute myeloid leukemia (AML). It works by inhibiting specific mutations in the FLT3 receptor, which are associated with leukemia cell proliferation, thereby reducing the growth of cancer cells.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Gilteritinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Gilteritinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Gilteritinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
